首页>Clinical and experimental rheumatology>Intravenous versus oral cyclophosphamide for lung and/or skin fibrosis in systemic sclerosis: an indirect comparison from EUSTAR and randomised controlled trials
Intravenous versus oral cyclophosphamide for lung and/or skin fibrosis in systemic sclerosis: an indirect comparison from EUSTAR and randomised controlled trials
作者单位：Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Pulm Med & Crit Care, Los Angeles, CA[1]Georgetown Univ, Dept Med, Div Rheumatol, Washington, DC USA[2]Univ Firenze, Div Rheumatol, Dept Expt & Clin Med, Via Oblate 4, I-50141 Florence, Italy[3]Univ Calif Los Angeles, Dept Med Stat Core, Los Angeles, CA 90024 USA[4]Univ Hosp Zurich, Dept Rheumatol, Zurich, Switzerland[5]Univ Paris 05, Sorbonne Paris Cite, Hop Cochin, Serv Rhumatol A, Paris, France[6]
换一批
